EcoDrugPlus

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSCHAG00000016530
Gene Symbol: MTOR
1 Cross references
223 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSCHAG00000002013
Gene Symbol: MC1R
3 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSCHAG00000019226
Gene Symbol: MC4R
3 Cross references
202 Possible Orthologues:

Melanocortin Receptor 4-Like

Ensembl ID : ENSCHAG00000005088
Gene Symbol: LOC105900484
3 Cross references
153 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSCHAG00000018970
Gene Symbol: MTNR1A
1 Cross references
138 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSCHAG00000018743
Gene Symbol: MTNR1AA
1 Cross references
190 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSCHAG00000019959
Gene Symbol: MME
3 Cross references
234 Possible Orthologues:

Membrane Primary Amine Oxidase-Like

Ensembl ID : ENSCHAG00000008581
Gene Symbol: LOC105899870
3 Cross references
413 Possible Orthologues:

Metabotropic Glutamate Receptor 2-Like

Ensembl ID : ENSCHAG00000025014
Gene Symbol: LOC105897819
3 Cross references
210 Possible Orthologues:

Methionine Aminopeptidase 2-Like

Ensembl ID : ENSCHAG00000016519
Gene Symbol: LOC105913452
3 Cross references
228 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSCHAG00000026107
Gene Symbol: MAPK1
3 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSCHAG00000020156
Gene Symbol: MAPK10
1 Cross references
222 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).